Cantillon: Emerging markets surprise observers with vaccine preferences

Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge

Another 11,671 PCR-confirmed coronavirus cases reported in past few days

Emily O’Reilly criticises executive for not disclosing Von Der Leyen messages

Companies to test fourth dose of current vaccine against fourth dose of new one

Dr Barney Graham’s discovery was a key step in development of Covid-19 vaccines

In lab tests the drug maintained its antiviral activity against all variants of concern

Drugmakers hope to build on success of Covid vaccine

Next year may bring good news but many of the concerns of 2021 will not have gone away

Next phase of vaccination programme in January complicated by multiple rollouts

More than 1.3 million boosters are given in State so far in race against highly contagious Omicron variant

Data shows no need for variant-specific vaccines, says Biden’s chief medical adviser

Registration for ages five to 11 will open shortly, with priority for those more at risk

Israeli research compared blood samples between two-dose group and booster group

Omicron expected to overtake the dominant Delta variant in the UK ‘by mid-December’

US indices rise as inflation report is in line with expectations

Increased restrictions to contain the Omicron coronavirus variant temper optimism

‘Yo-yo day’ prevails on Dublin stock market

Third vaccine dose as effective as second shot was in fighting original virus, study finds

Total global output will be more than 20 billion shots for the year